Eunice Wang, MD, Roswell Park Comprehensive Cancer Center
Advertisement
Articles by Eunice Wang, MD, Roswell Park Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Optimizing Treatment Selection for Patients with FLT3-ITD AMLPublished: July 24th 2023 | Updated:
Using MRD to Monitor Therapeutic Response in ALLPublished: June 30th 2021 | Updated:
- Standard Approach to Treatment for Fit Patients with Newly Diagnosed AML
Published: July 17th 2023 | Updated:
- An Introduction to Biomarker Testing in Acute Myeloid Leukemia
Published: June 26th 2023 | Updated:
The Evolving Treatment Landscape for ALLPublished: June 30th 2021 | Updated:
- Clinical Insights Concerning Molecular Testing in Patients Diagnosed with Acute Myeloid Leukemia
Published: July 17th 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5